Our Mission


Welcome to Greehey Children's Cancer Research Institute


Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (GCCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of causes of childhood cancer, and accelerate the translation of knowledge into novel therapies. Through discovery, development  and dissemination of new scientific knowledge, GCCRI strives to have a national and global impact on the problem of childhood cancer. Our mission consists of three key areas — research, clinical and education.



The areas of our research that have been our strengths include cancer genomics and microRNA biology. We are developing expertise in drug delivery, with a focus on nano-technology driven delivery of microRNA mimics and antagomiRs, which will be further developed in the coming year. With recruitment of the new director, our focus on developmental therapeutics will increase dramatically in the next few years.

The Pediatric Translational Working Group formed last year under the guidelines of the UT Health Cancer Center P30 format, now meets regularly. The purpose of this group is to coordinate discoveries with application to development of novel therapies.

RESEARCH FOCUS: Bioinformatics and genomics, cancer biology, cancer control, experimental therapeutics, genome instability, molecular oncogenesis and RNA biology.

CORE FACILITIES: Computational biology and bioinformatics, genomic sequencing, PDX generation, RNAi/CRISPR HTS and small molecule HTS.



Greehey CCRI interacts with members of the UT Health San Antonio, Division of Pediatric Hematology-Oncology to provide support for clinical research, banking of clinical specimens, and annotation of such specimens to facilitate patient-oriented research. In addition, as our clinical mission includes performing research that translates into clinical care, Greehey CCRI supports infrastructure for human subjects’ research and investigator-initiated trials in pediatric cancer. Since much of research in pediatric cancer includes participation in cooperative group trials, Greehey CCRI supports the involvement of investigators in Children’s Oncology Group participation.

This year, the Mays Cancer Center at UT Health San Antonio MD Anderson, has become a member of The Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC) pediatric oncology studies focus on the biologic basis for anti-cancer therapy, and in particular, attempt to explore and evaluate new agents and novel combinations of therapies early in clinical development.



The educational mission of the Greehey Children's Cancer Research Institute is to train the next generation of researchers in pediatric cancer research. This includes creating a pipeline of trainees through our program for undergraduates engaged in summer research, medical students within the MD with Distinction in Research program, fellows in the ACGME-approved hematology-oncology fellowship program, as well as the traditional graduate programs in Cancer Biology and other relevant areas. We also provide a nurturing home for post-doctoral graduate research training. In the past five years we have graduated 8 new Ph.D.s, and trained 4 pediatric oncology fellows as well as hosted several dozen summer undergraduate students.